Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300723 stock hub

SHE/300723 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300723is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.3B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300723

In the news

Latest news · SHE/300723

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E91.7

P25 23.5P50 41.3P75 83.2

ROE9.7

P25 -0.9P50 4.1P75 8.8

ROIC-10.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300723 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

CNY

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,294
Employees Change	-190%
Employees Change Percent	-12.8
Enterprise value	CNY 19.9B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000035J7
Last refreshed	2026-05-10
Market cap	CNY 18.3B
Price	CNY 40.85
Price currency	CNY
Rev Per Employee	727,030.65x
Sector	Healthcare
Sic	2834
Symbol	she/300723
Website	https://www.apichope.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.09%
EV Earnings	99.69x
EV/FCF	-233.43x
EV/Sales	21.39x
FCF yield	-0.47%
P/B ratio	9.31x
P/E ratio	91.72x
P/S ratio	19.5x
PE Ratio10 Y	48.51x
PE Ratio5 Y	61.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-32.16%
EBITDA Margin	-11.52%
Gross margin	57.41%
Gross Profit	CNY 540.1M
Gross Profit Growth	-14.57%
Gross Profit Growth Q	10.68%
Gross Profit Growth3 Y	-36.73%
Gross Profit Growth5 Y	-18.84%
Net Income	CNY 200M
Net Income Growth Q	950.35%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	-14.68%
Net Income Growth5 Y	-4.4%
Pretax Margin	17.34%
Profit Margin	21.26%
Profit Per Employee	CNY 154,554
ROA	-3.8
Roa5y	0.91
ROCE	-9.27
ROE	9.73
Roe5y	-2.03
ROIC	-10.77
Roic5y	1.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.32%
Cagr3y	8.95%
Cagr5y	19.25%
Div CAGR3	-4.45%
Div CAGR5	10.13%
EPS Growth Q	950.2
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	-15.56
EPS Growth5 Y	-5.24
FCF Growth Q	-47.78%
OCF Growth Q	-51.2%
OCF Growth3 Y	-61.98%
OCF Growth5 Y	-40.08%
Revenue Growth	-21.88x
Revenue Growth Q	2.26x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-27.61x
Revenue Growth5 Y	-12.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.19
Assets	CNY 4.7B
Cash	CNY 1.4B
Current Assets	CNY 2.1B
Current Liabilities	CNY 1.4B
Debt	CNY 2.1B
Debt Equity	CNY 1.06
Debt FCF	CNY -24.4
Equity	CNY 2B
Interest Coverage	-5.24
Liabilities	CNY 2.7B
Long Term Assets	CNY 2.6B
Long Term Liabilities	CNY 1.3B
Net Cash	CNY -682.9M
Net Cash By Market Cap	CNY -3.72
Net Debt Equity	CNY 0.35
Tangible Book Value	CNY 1.6B
Tangible Book Value Per Share	CNY 3.46
WACC	7.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.45
Inventory Turnover	1.63
Net Working Capital	CNY 158.9M
Quick ratio	1.22
Working Capital	CNY 644.1M
Working Capital Turnover	CNY 2.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.02%
Dividend per share	CNY 0
Last Dividend	CNY 0.21
Payout Ratio	30.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.31%
200-day SMA	48.36
3Y total return	29.34%
50-day SMA	34.68
50-day SMA vs 200-day SMA	50under200
5Y total return	141.12%
All Time High	81.48
All Time High Change	-49.87%
All Time High Date	2025-08-01
All Time Low	7.58
All Time Low Change	439.06%
All Time Low Date	2017-11-16
ATR	2.37
Beta	0.69
Beta1y	0.35
Beta2y	0.46
Ch YTD	21.76
High	43.36
High52	81.48
High52 Date	2025-08-01
High52ch	-49.86%
Low	40.83
Low52	29.31
Low52 Date	2026-03-23
Low52ch	39.37%
Ma50ch	17.78%
Price vs 200-day SMA	-15.53%
RSI	61.95
RSI Monthly	53.02
RSI Weekly	52.13
Sharpe ratio	0.34x
Sortino ratio	0.62
Total Return	-0.02%
Tr YTD	21.76
Tr1m	13.79%
Tr1w	-6.31%
Tr3m	20.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY -302.6M
Operating margin	-32.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	160,334,931%
Net Borrowing	-373,764,264
Shares Insiders	21.11%
Shares Institutions	19.14%
Shares Out	449,027,176
Shares Qo Q	-0.05%
Shares Yo Y	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -85.4M
Average Volume	20,850,219.4x
Bv Per Share	4.29
CAPEX	CNY -111.8M
Ch1m	13.79
Ch1w	-6.31
Ch1y	9.31
Ch3m	20.57
Ch3y	27.6
Ch5y	136.2
Ch6m	-16.43
Change	-4.11%
Change From Open	-4.44
Close	42.6
Days Gap	0.35
Depreciation Amortization	194,183,729
Dollar Volume	1,016,462,420.9
Earnings Date	2026-04-24
EBIT	CNY -302.6M
EBITDA	CNY -108.4M
EPS	CNY 0.44
F Score	5
FCF	CNY -85.4M
FCF EV Yield	-0.43x
FCF Per Share	CNY -0.19
Financing CF	-659,612,139
Fiscal Year End	December
Founded	2,002
Goodwill	255,936
Graham Number	6.53366
Graham Upside	-84.01
Income Tax	CNY -29.6M
Investing CF	1,032,992,805
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2023-05-24
Last Split Type	Forward
Lynch Fair Value	CNY 2.21
Lynch Upside	-94.58
Ma150	41.8
Ma150ch	-2.27%
Ma20	37.77
Ma20ch	8.15%
Net CF	399,024,979
Next Earnings Date	2026-08-24
Open	42.75
P OCF Ratio	695.3
Position In Range	0.79
Ppne	1,732,149,160
Price Date	2026-05-08
Ptbv Ratio	11.75
Relative Volume	1.21x
Revenue	940,777,655x
Tax By Revenue	-3.15x
Tr6m	-16.43%
Volume	24,882,801

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHE/300723 pay a dividend?

Capital-return profile for this ticker.

Performance

SHE/300723 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300723?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.1%

Share of float held by funds and institutions

Insider ownership

+21.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

SHE/300723 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.9

Neutral momentum band

Price vs 200-day MA

-15.5%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300723

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300723 stock rating?

she/300723 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300723 analysis?

The full report lives at /stocks/she/300723/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300723?

The latest report frames she/300723 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300723 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.